#news #biotech K36 emerges with $30M to bankroll multiple myeloma drug in-licensed from Novartis

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: K36 emerges with $30M to bankroll multiple myeloma drug in-licensed from Novartis .K36 emerges with $30M to bankroll multiple myeloma drug in-licensed from Novartis
klahucik
Thu, 12/09/2021 – 08:31

from FierceBiotech: Biotech https://ift.tt/3GvevEy